Nephrology Medical News about phosphorus management

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fibroblast growth factor 23 and the future of phosphorus management
Current Opinion in Nephrology and Hypertension, 10/15/09

Wolf M – FGF23 is emerging as a novel and exciting biomarker that may help identify which CKD patients might benefit most from aggressive management of disordered phosphorus metabolism. Future studies should determine whether increased FGF23 levels exert direct end–organ toxicity, such as in the heart, vessels and kidneys.

<< Previous
Relationships between Potential Immune Molecules in the Lowest...

Next >>
New insights into the role of anabolic interventions in dialysis...

Uraemic pruritus: starting from scratch to relieve itch
Drugs & Therapy Perspectives, 10/16/09 Relevance Score: 64%

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09 Relevance Score: 46%

Insight Health Apppints James Shriver VP of Sales Marketing
Imaging Economics, 10/15/09 Relevance Score: 46%

Barriers and Facilitators to Chronic Pain Self-Management: A Qualitative Study of Primary Care Patients with Comorbid Musculoskeletal Pain and Depression
Pain Medicine, 10/14/09 Relevance Score: 46%

Self-Management of Chronic Neck and Low Back Pain and Relevance of Information Provided During Clinical Encounters: An Observational Study
Archives of Physical Medicine and Rehabilitation, 10/06/09 Relevance Score: 46%